Biomarkers for Recurrent Rectal Cancer Outcomes
Identifying molecular biomarkers could enhance patient selection for salvage surgery in locally recurrent rectal cancer, impacting surgical strategies and patient outcomes.
Newsletter
Every new paper in this field, in your inbox.
Identifying molecular biomarkers could enhance patient selection for salvage surgery in locally recurrent rectal cancer, impacting surgical strategies and patient outcomes.
Surgeons should note that early onset colorectal cancer (diagnosed before age 50) is distinct from late-onset cases, significantly impacting risk assessment and treatment.
Negative pressure wound therapy (NPWT) doesn't cut surgical site infections but speeds up healing after stoma reversal.
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly improve outcomes for patients with colorectal peritoneal metastases.
A machine learning model can predict anastomotic leakage within 24 hours post-minimally invasive colorectal surgery, enhancing patient selection and safety.
Indocyanine green fluorescence angiography significantly lowers anastomotic leakage rates in colorectal surgery, improving patient outcomes.
A new study compares long-term results of laser hemorrhoidoplasty, excisional hemorrhoidectomy, and sutured mucopexy for treating second- and third-degree hemorrhoids.
A newly approved Japanese robotic surgical platform shows promise for colorectal surgeries by improving outcomes and cost-effectiveness.
Obese patients face higher readmission rates after laparoscopic colectomy, influencing surgical decisions.
Combining anatomical and histologic responses to neoadjuvant therapy improves predicting recurrence in colorectal liver metastases (CRLM) after hepatectomy.